Jennifer A. Belisle

发表

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

Mitchell Ho, I. Pastan, Byungkook Lee, 2006, Molecular Cancer.

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells

C. Rancourt, M. Patankar, S. Horibata, 2010, Molecular Cancer.

Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin.

M. Patankar, D. Kushner, P. Hutson, 2009, Gynecologic oncology.

Research of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

C. Rancourt, J. Paulson, M. Patankar, 2010 .

Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

A. Dell, H. Morris, M. Patankar, 2005, Gynecologic oncology.

Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)

C. Rancourt, M. Patankar, J. Connor, 2007, Immunology.

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

C. Rancourt, J. Paulson, M. Patankar, 2010, Molecular Cancer.

The Mucin MUC16 (CA125) Binds to NK Cells and Monocytes from Peripheral Blood of Women with Healthy Pregnancy and Preeclampsia

M. Patankar, J. Connor, M. Felder, 2012, American journal of reproductive immunology.

Characterization of the tumor marker muc16 (ca125) expressed by murine ovarian tumor cell lines and identification of a panel of cross-reactive monoclonal antibodies

C. Rancourt, Michaela Zwick, M. Patankar, 2009, Journal of ovarian research.